Related references
Note: Only part of the references are listed.Apolipoprotein E genotype-dependent nutrigenetic effects to prebiotic inulin for modulating systemic metabolism and neuroprotection in mice via gut-brain axis
Lucille M. Yanckello et al.
NUTRITIONAL NEUROSCIENCE (2022)
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance
Geetika Nehra et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Accelerated Failure Time Survival Model to Analyze Morris Water Maze Latency Data
Clark R. Andersen et al.
JOURNAL OF NEUROTRAUMA (2021)
New Evidence for P-gp-Mediated Export of Amyloid-β Peptides in Molecular, Blood-Brain Barrier and Neuronal Models
Amanda B. Chai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Protecting P-glycoprotein at the blood-brain barrier from degradation in an Alzheimer's disease mouse model
Yujie Ding et al.
FLUIDS AND BARRIERS OF THE CNS (2021)
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice
Stefano Fogli et al.
PHARMACOLOGICAL RESEARCH (2021)
Ixazomib-based frontline therapy in patients with newly diagnosed multiple myeloma in real-life practice showed comparable efficacy and safety profile with those reported in clinical trial: a multi-center study
Jing Li et al.
ANNALS OF HEMATOLOGY (2020)
APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease
Ai-Ling Lin et al.
NEUROBIOLOGY OF DISEASE (2020)
Mamma Mia, P-glycoprotein binds again
Richard Callaghan et al.
FEBS LETTERS (2020)
Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib
Carlyn Rose C. Tan et al.
CLINICAL PHARMACOKINETICS (2019)
Preventing P-gp Ubiquitination Lowers A beta Brain Levels in an Alzheimer's Disease Mouse Model
Anika M. S. Hartz et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease
Jennifer Lee et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results
Andrew Spencer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter
Pavitra Kannan et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier
Kaijun Di et al.
NEURO-ONCOLOGY (2016)
A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β-Peptide from the Brain
Wei Wang et al.
CURRENT ALZHEIMER RESEARCH (2016)
Rapid in vivo measurement of β-amyloid reveals biphasic clearance kinetics in an Alzheimer's mouse model
Carla M. Yuede et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway
Anika M. S. Hartz et al.
JOURNAL OF NEUROSCIENCE (2016)
RSK1 protects P-glycoprotein/ABCB1 against ubiquitin-proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1
Kazuhiro Katayama et al.
SCIENTIFIC REPORTS (2016)
The multidrug resistance pump ABCB1 is a substrate for the ubiquitin ligase NEDD4-1
Begum G. Akkaya et al.
MOLECULAR MEMBRANE BIOLOGY (2015)
P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations
Catherine Chiu et al.
NEUROBIOLOGY OF AGING (2015)
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease
Anand K. Deo et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy
Anna Carrano et al.
NEUROBIOLOGY OF AGING (2014)
FBXO15 regulates P-glycoprotein/ABCB1 expression through the ubiquitinproteasome pathway in cancer cells
Kazuhiro Katayama et al.
CANCER SCIENCE (2013)
From Bortezomib to other Inhibitors of the Proteasome and Beyond
Daniela Buac et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Oatp1a4 and an L-Thyroxine-Sensitive Transporter Mediate the Mouse Blood-Brain Barrier Transport of Amyloid-β Peptide
Tuan Minh Do et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Blood-brain barrier P-glycoprotein function in Alzheimer's disease
Danielle M. E. van Assema et al.
BRAIN (2012)
Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice
Markus Krohn et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The Case for Blood-Brain Barrier Dysfunction in the Pathogenesis of Alzheimer's Disease
Brian Jeynes et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis
Brian Jeynes et al.
NEUROSCIENCE LETTERS (2011)
ABC efflux transporters in brain vasculature of Alzheimer's subjects
Hasini C. Wijesuriya et al.
BRAIN RESEARCH (2010)
Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid-β in a Mouse Model of Alzheimer's Disease
Anika M. S. Hartz et al.
MOLECULAR PHARMACOLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Clearance of Amyloid-beta Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
R. Deane et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta
Leon M. Tai et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Binding site of loperamide:: Automated docking of loperamide in human μ- and δ-opioid receptors
Antonio Mazzella di Bosco et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier
Anika M. S. Hartz et al.
FASEB JOURNAL (2008)
The ubiquitin-proteasome system in Alzheimer's disease
Salvatore Oddo
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
MDR1-P-glycoprotein (ABCB1) mediates transport of Alzheimer's amyloid-β peptides -: Implications for the mechanisms of Aβ clearance at the blood-brain barrier
Diana Kuhnke et al.
BRAIN PATHOLOGY (2007)
In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2006)
β-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system
CG Almeida et al.
JOURNAL OF NEUROSCIENCE (2006)
Rapid modulation of p-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-α and lipopolysaccharide
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2006)
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model
JR Cirrito et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Neurovascular mechanisms of Alzheimer's neurodegeneration
BV Zlokovic
TRENDS IN NEUROSCIENCES (2005)
Regulation of the stability of P-glycoprotein by ubiquitination
ZG Zhang et al.
MOLECULAR PHARMACOLOGY (2004)
Rapid regulation of P-glycoprotein at the blood-brain barrier by endothelin-1
AMS Hartz et al.
MOLECULAR PHARMACOLOGY (2004)
Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease
S Keck et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
β-Amyloid efflux mediated by p-glycoprotein
FC Lam et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Impaired proteasome function in Alzheimer's disease
JN Keller et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system
JJ Gribar et al.
JOURNAL OF MEMBRANE BIOLOGY (2000)
Share Paper
